Chemical mapping of anxiety in the brain of healthy humans: An in vivo (1)H‐MRS study on the effects of sex, age, and brain region

Autor Grachev, Igor D., Apkarian, A. Vania
Vydáno v Hum Brain Mapp (2000)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes

Autor Bajaj, Nin, Hauser, Robert A, Grachev, Igor D
Vydáno 2013

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in s...

Autor Bajaj, Nin, Hauser, Robert A, Seibyl, John, Kupsch, Andreas, Plotkin, Michail, Chen, Chris, Grachev, Igor D
Vydáno v Alzheimers Res Ther (2014)

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials

Autor O'Brien, John T, Oertel, Wolfgang H, McKeith, Ian G, Grosset, Donald G, Walker, Zuzana, Tatsch, Klaus, Tolosa, Eduardo, Sherwin, Paul F, Grachev, Igor D
Vydáno 2014

Characterizing patient compliance over six months in remote digital trials of Parkinson’s and Huntington disease

Autor Cohen, Shani, Waks, Zeev, Elm, Jordan J., Gordon, Mark Forrest, Grachev, Igor D., Navon-Perry, Leehee, Fine, Shai, Grossman, Iris, Papapetropoulos, Spyros, Savola, Juha-Matti
Vydáno v BMC Med Inform Decis Mak (2018)

An In Vivo Evaluation of Cerebral Cortical Amyloid with [(18)F]Flutemetamol Using Positron Emission Tomography Compared with Parietal Biopsy Samples in Living Normal Pressure Hydro...

Autor Wong, Dean F., Moghekar, Abhay R., Rigamonti, Daniele, Brašić, James R., Rousset, Olivier, Willis, William, Buckley, Chris, Smith, Adrian, Gok, Beril, Sherwin, Paul, Grachev, Igor D.
Vydáno 2013

Diagnostic effectiveness of quantitative [(18)F]flutemetamol PET imaging for detection of fibrillar amyloid β using cortical biopsy histopathology as the standard of truth in subje...

Autor Leinonen, Ville, Rinne, Juha O, Wong, Dean F, Wolk, David A, Trojanowski, John Q, Sherwin, Paul F, Smith, Adrian, Heurling, Kerstin, Su, Mandy, Grachev, Igor D
Vydáno 2014

Association between in vivo [(18)F]-flutemetamol amyloid PET imaging and in vivo cerebral cortical histopathology

Autor Wolk, David A., Grachev, Igor D., Buckley, Chris, Kazi, Hala, Grady, M. Sean, Trojanowski, John Q., Hamilton, Roy H., Sherwin, Paul, McLain, Richard, Arnold, Steven E.
Vydáno v Arch Neurol (2011)

Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor Devices

Autor Gordon, Mark Forrest, Grachev, Igor D., Mazeh, Itzik, Dolan, Yonatan, Reilmann, Ralf, Loupe, Pippa S., Fine, Shai, Navon-Perry, Leehee, Gross, Nicholas, Papapetropoulos, Spyros, Savola, Juha-Matti, Hayden, Michael R.
Vydáno v Digit Biomark (2019)

Pharmacokinetics, metabolism and safety of deuterated L‐DOPA (SD‐1077)/carbidopa compared to L‐DOPA/carbidopa following single oral dose administration in healthy subjects

Autor Schneider, Frank, Erisson, Lavi, Beygi, Hooman, Bradbury, Margaret, Cohen‐Barak, Orit, Grachev, Igor D., Guzy, Serge, Loupe, Pippa S., Levi, Micha, McDonald, Mirna, Savola, Juha‐Matti, Papapetropoulos, Spyros, Tracewell, William G., Velinova, Maria, Spiegelstein, Ofer
Vydáno v Br J Clin Pharmacol (2018)

Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [(18)F] fluspidine and [(18)F] fallypride PET study

Autor Grachev, Igor D., Meyer, Philipp M., Becker, Georg A., Bronzel, Marcus, Marsteller, Doug, Pastino, Gina, Voges, Ole, Rabinovich, Laura, Knebel, Helena, Zientek, Franziska, Rullmann, Michael, Sattler, Bernhard, Patt, Marianne, Gerhards, Thilo, Strauss, Maria, Kluge, Andreas, Brust, Peter, Savola, Juha-Matti, Gordon, Mark F., Geva, Michal, Hesse, Swen, Barthel, Henryk, Hayden, Michael R., Sabri, Osama
Vydáno v Eur J Nucl Med Mol Imaging (2020)